The USCOM 1A non-invasive Doppler monitor with advanced hemodynamics provides rapid, reliable and repeatable serial hemodynamic monitoring for personalized management of fluid, sepsis, heart failure and hypertension. The USCOM 1A is validated from 0.12 l/min to 17 l/min and from 26 weeks gestational age to 110 years.
Preload - Fluid management, fluid responsiveness and fluid optimization; when to start and when to stop fluid.
Sepsis - Hemodynamic status, including DO2, Stroke Volume (SV) and Cardiac Output (CO) optimization.
Shock - Shock differentiation with identification of underlying hemodynamic derangements.
Cardiac Function - Assessment of systolic function, heart failure and cardiopulmonary exercise testing.
Hypotension - Differentiate and identify SVR and CO/SV derangement.
Hypertension - Differentiate and identify SVR and CO/SV derangement.
Pediatrics - Identifies distinct patterns of shock and monitors therapy. USCOM 1A is applicable for fluid, sepsis and shock management and systolic function assessment of cardio toxic oncology patients. More info
Critical Care Medicine - Less than 50% of ICU patients given fluid boluses are volume responsive. USCOM 1A provides non-invasive Stroke Volume monitoring to increase sensitivity and specificity in excess of 90%. USCOM 1A is applicable for hemodynamic and ventilation management in the Medical and Surgical ICU, the stepdown unit and outreach. More info
Emergency Medicine - USCOM 1A provides front line hemodynamic assessment and detection of hypotension, shock differentiation, early sepsis management, triage and retrieval. More info
Perioperative Medicine - Normal Cardiac Output pre-anesthesia improves anesthetic outcome. Perioperative fluid and hemodynamic optimization improves recovery time and patient outcomes and reduces cost. USCOM 1A is used for pre-operative assessment, perioperative management and post-surgical monitoring. More info
Maternal Medicine - Pre-eclampsia occurs in 3-5% of all pregnancies which results in poor maternal and fetal outcomes and is responsible for 15-20% of all maternal deaths. USCOM 1A detects early pre-eclampsia and is used in Maternal-Fetal and IVF clinics and the Maternal ICU for gestational hypertension, intrauterine growth retardation. More info
Neonatology - Neonatal sepsis is a leading cause of infant death. The quicker an infant receives treatment, the better the outcome. Serial measurement of SVI, CI and SVRI monitors hemodynamic changes and identifies optimal therapeutic response. More info
Liver Transplantation - Massive fluid shifts of intravascular volume and high blood loss characterise liver transplantation surgery and require monitoring of Stroke Volume and Cardiac Output.
Outpatient Clinic - Non-invasive, rapid and reproducible assessment of hemodynamics in the Hypertension, Heart Transplantation, Heart Failure and Maternal-Fetal clinic.
Drug Trials - Implantation of a device or administration of drugs requires CO monitoring.
Veterinary Practice and Animal Research - The non-invasive USCOM 1A is an ethical alternative for measuring circulation in animals from mice to gorillas.
USCOM 1A is an advanced non-invasive, specialized Doppler ultrasound device designed specifically for rapid, reliable and reproducible optimization of the circulation, in the most cost effective way.